The Charcot-Marie-Tooth (CMT) Self-Assessment (SA) built in partnership with the Hereditary Neuropathy Foundation (HNF) tests your knowledge on recent advances in CMT, the ability to diagnose patients with CMT, and the application of CMT knowledge in clinical practice. The American Board of Psychiatry and Neurology (ABPN) and the American Board of Physical Medicine and Rehabilitation (ABPMR) have reviewed and approved this product as part of a comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of maintenance of certification (MOC). You will also receive additional information from HNF regarding research, patient resources and supporting materials.

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the AANEM and HNF. The AANEM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DISCLOSURE INFORMATION
Dr. Thomas is a consultant for PharNEXT. Dr. Walk in on an advisory committee, receives research funding and honorarium from Acceleron Pharma and receives research funding from PharNEXT. No others in control of content had conflicts to disclose. All conflicts of interest have been resolved according to ACCME standards.

CREDIT DESIGNATION
The AANEM designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credits ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit expires July 1, 2025.